Form 8-K - Current report:
SEC Accession No. 0000318306-10-000014
Filing Date
2010-02-08
Accepted
2010-02-08 15:52:32
Documents
2
Period of Report
2010-02-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K r8k-267.htm 8-K 31010
2 EXHIBIT 10-31 r8k-268.htm EX-10.31 53467
  Complete submission text file 0000318306-10-000014.txt   86275
Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
ACCESS PHARMACEUTICALS INC (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15771 | Film No.: 10580949
SIC: 2834 Pharmaceutical Preparations